Table 3. The clinical and biochemical characteristics of SAA1 rs10832915 polymorphism between two groups.

	Patients (n=300)				Controls (n=350)
	TT (n=108)	TC (n=140)	CC (n=52)	P	TT (n=148)	TC (n=158)	CC (n=44)	P
Age (years)	46.74 ± 4.46	46.58 ± 4.35	46.96 ± 4.88	0.866	46.57 ± 5.03	47.27 ± 5.06	46.50 ± 4.76	0.408
BMI (kg/m2)	24.45 ± 1.41	24.47 ± 1.49	24.12 ± 1.40	0.283	24.30 ± 1.45	24.29 ± 1.62	23.91± 1.31	0.310
TC (mmol/l)	4.48 ± 0.94	4.52 ± 0.98	4.41 ± 0.96	0.794	4.30 ± 0.85	4.43 ± 0.86	4.46 ± 0.74	0.329
HDL (mmol/l)	1.22 ± 0.37	1.19 ± 0.34	1.21 ± 0.38	0.730	1.22 ± 0.35	1.25 ± 0.35	1.27 ± 0.43	0.676
LDL (mmol/l)	2.68 ± 0.80	2.61 ± 0.84	2.46 ± 0.90	0.293	2.42 ± 0.70	2.50 ± 0.78	2.25 ± 0.73	0.148
T-score	−3.09 ± 0.54	−3.00 ± 0.61	−2.95 ± 0.57	0.255	0.14 ± 0.11	0.14 ± 0.11	0.13 ± 0.10	0.877
Z-score	−2.11 ± 0.41	-2.06 ± 0.47	−2.11 ± 0.55	0.615	0.62 ± 0.17	0.66 ± 0.19	0.60 ± 0.17	0.094